Ikarian Capital, LLC Soleno Therapeutics Inc Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.14 - $0.23 $17,983 - $29,544	-128,454 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.22 - $0.47 $1,487 - $3,177	6,760 Added 5.55%	128,454 $29,000
Q3 2021 Nov 15, 2021	SELL	$0.8 - $1.12 $614 - $860	-768 Reduced 0.63%	121,694 $112,000
Q4 2020 Feb 12, 2021	BUY	$1.61 - $2.23 $197,163 - $273,090	122,462 New	122,462 $236,000
Q3 2020 Nov 16, 2020	SELL	$1.71 - $2.51 $575,929 - $845,370	-336,801 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.23 $596,137 - $1.42 Million	336,801 New	336,801 $748,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $420M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.